Public procurement / RFP

By following point 10 of Chapter VI, the ordering party informs that within the request for proposals for

pre-clinical tests (physiochemical, ADME-tox, genotoxicity, safety pharmacology and toxicological tests) necessary to commence 1st phase clinical trials for EC313,

conducted in the mode of inquiry based on the provisions of the Act of April 23, 1964 – the Civil Code (Journal of Laws 2014, item 212, as amended), questions were recieved. Please find the questions and answers are below:

ZO-07-2017_answers-to-the-questions_3

By following point 10 of Chapter VI, the ordering party informs that within the request for proposals for

pre-clinical tests (physiochemical, ADME-tox, genotoxicity, safety pharmacology and toxicological tests) necessary to commence 1st phase clinical trials for EC313,

conducted in the mode of inquiry based on the provisions of the Act of April 23, 1964 – the Civil Code (Journal of Laws 2014, item 212, as amended), questions were recieved. Please find the questions and answers are below:

ZO-07-2017_Answers-to-the-questions_2

By following point 10 of Chapter VI, the ordering party informs that within the request for proposals

pre-clinical tests (physiochemical, ADME-tox, genotoxicity, safety pharmacology and toxicological tests) necessary to commence 1st phase clinical trials for EC313,

conducted in the mode of inquiry based on the provisions of the Act of April 23, 1964 – the Civil Code (Journal of Laws 2014, item 212, as amended), questions were recieved. Please find the questions and answers are below:

ZO-07-2017_Answers-to-the-questions_1

In relation to implementation of the project No. POIR.01.01.01-00-0123/16 entitled “The development of selective treatment of endometriosis based on mesoprogestins“, conducted within Action 1.1. „R&D projects of enterprises”, Sub-action 1.1.1. „Industrial research and development works carried out by enterprises” in frame of Priority I of POIR 2014 – 2020″ as well in connection with the obligation to apply the competitive principle (principle of fair competition) Evestra Onkologia Sp. z o. o. invites to submit offers for successive supply of:

pre-clinical tests (physiochemical, ADME-tox, genotoxicity, safety pharmacology and toxicological tests) necessary to commence 1st phase clinical trials for EC313.

ZO-07-2017eng
Attachment-no-1-ZO-07-2017
Attachment-no-2-ZO-07-2017
Attachment-no-3-ZO-07-2017
Attachment-no-4-ZO-07-2017
Attachment-no-5-ZO-07-2017

By following point 10 of Chapter VI, the ordering party informs that within the request for proposals for supply of raw materials, intermediates, solvents, catalysts and other substances as well as analytical supply for active substance synthesis carried out for the research carried out in the project, conducted in the mode of inquiry based on the provisions of the Act of April 23, 1964 – the Civil Code (Journal of Laws 2014, item 212, as amended), questions were recieved. Please find the questions and answers are below:

ZO-02-2017_Answers-to-the-questions_1-1

In relation to implementation of the project No. POIR.01.01.01-00-0123/16 entitled „The development of selective treatment of endometriosis based on mesoprogestins„, conducted within Action 1.1. „R&D projects of enterprises”, Sub-action 1.1.1. „Industrial research and development works carried out by enterprises” in frame of Priority I of POIR 2014 – 2020″ as well in connection with the obligation to apply the competitive principle (principle of fair competition) Evestra Onkologia Sp. z o. o. invites to submit offers for successive supply of: successive supply of chemical reagents and biological materials, disposables as well as small laboratory equipment for research carried out in the project.

Files to download:

request_for_proposals-ZO-03-2017
ZO-03-2017_APPENDIX_1
ZO-03-2017_APPENDIX_2
ZO-03-2017_APPENDIX_3

In relation to implementation of the project No. POIR.01.01.01-00-0123/16 entitled „The development of selective treatment of endometriosis based on mesoprogestins„, conducted within Action 1.1. „R&D projects of enterprises”, Sub-action 1.1.1. „Industrial research and development works carried out by enterprises” in frame of Priority I of POIR 2014 – 2020″ as well in connection with the obligation to apply the competitive principle (principle of fair competition) Evestra Onkologia Sp. z o. o. invites to submit offers for supply of: raw materials, intermediates, solvents, catalysts and other substances as well as analytical supply for active substance synthesis carried out for the research carried out in the project.

request_for_proposals_ZO-02-2017
ZO-02-2017_APPENDIX_1
ZO-02-2017_APPENDIX_2
ZO-02-2017_APPENDIX_3